BR0012921A - Compostos calcilìticos - Google Patents
Compostos calcilìticosInfo
- Publication number
- BR0012921A BR0012921A BR0012921-6A BR0012921A BR0012921A BR 0012921 A BR0012921 A BR 0012921A BR 0012921 A BR0012921 A BR 0012921A BR 0012921 A BR0012921 A BR 0012921A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- calcally
- disorders
- calculating
- new methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14677899P | 1999-07-31 | 1999-07-31 | |
| PCT/US2000/020834 WO2001008673A1 (en) | 1999-07-31 | 2000-07-31 | Calcilytic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0012921A true BR0012921A (pt) | 2002-06-18 |
Family
ID=22518969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0012921-6A BR0012921A (pt) | 1999-07-31 | 2000-07-31 | Compostos calcilìticos |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1200076A4 (cs) |
| JP (1) | JP2003505502A (cs) |
| KR (1) | KR20020016928A (cs) |
| CN (1) | CN1367687A (cs) |
| AU (1) | AU764716B2 (cs) |
| BR (1) | BR0012921A (cs) |
| CA (1) | CA2380081A1 (cs) |
| CO (1) | CO5180628A1 (cs) |
| CZ (1) | CZ2002360A3 (cs) |
| EC (1) | ECSP003590A (cs) |
| HK (1) | HK1046238A1 (cs) |
| HU (1) | HUP0202167A3 (cs) |
| IL (1) | IL147875A0 (cs) |
| MX (1) | MXPA02001204A (cs) |
| NO (1) | NO20020466L (cs) |
| PE (1) | PE20010459A1 (cs) |
| PL (1) | PL353318A1 (cs) |
| TR (1) | TR200200278T2 (cs) |
| UY (1) | UY26265A1 (cs) |
| WO (1) | WO2001008673A1 (cs) |
| ZA (1) | ZA200200784B (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY159417A (en) * | 2000-01-24 | 2017-01-13 | Smithkline Beecham Corp | Calcilytic compounds |
| US20030018203A1 (en) | 2002-07-17 | 2003-01-23 | Largo Maria Amparo | Calcilytic compounds |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| AR042132A1 (es) | 2002-11-26 | 2005-06-08 | Smithkline Beecham Corp | Compuesto de 2- hidroxi -3-(2- aril - 1, 1 - dimetiletilamino) propoxifenilo, composicion farmaceutica que lo comprende y uso del mismo para prepararla |
| US7205322B2 (en) | 2003-02-12 | 2007-04-17 | Bristol-Myers Squibb Company | Thiazolidine compounds as calcium sensing receptor modulators |
| US7265145B2 (en) | 2003-05-28 | 2007-09-04 | Bristol-Myers Squibb Company | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
| UY30801A1 (es) | 2006-12-18 | 2008-07-03 | Smithkline Beecham Corp | Compuestos calciliticos |
| WO2013098588A1 (en) * | 2011-12-27 | 2013-07-04 | Ubaldo Armato | Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies |
| GB201217330D0 (en) | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
| CN108420814A (zh) * | 2017-02-15 | 2018-08-21 | 四川大学 | 一种nps-2143用于抗菌的新用途 |
| CN116173187B (zh) * | 2023-03-14 | 2024-05-10 | 哈尔滨医科大学 | 降钙素在制备防治支架内再狭窄药物中的应用、药物涂层支架及制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ332068A (en) * | 1996-04-09 | 2001-03-30 | Smithkline Beecham | Alpha, alpha-disubstituted arylalkylamine derivatives as calcilytic compounds |
| PE20000415A1 (es) * | 1998-04-08 | 2000-05-21 | Smithkline Beecham Corp | Compuestos calciliticos |
| AR014975A1 (es) * | 1998-04-08 | 2001-04-11 | Nps Pharma Inc | Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento |
-
2000
- 2000-07-28 CO CO00056902A patent/CO5180628A1/es not_active Application Discontinuation
- 2000-07-28 EC EC2000003590A patent/ECSP003590A/es unknown
- 2000-07-31 PL PL00353318A patent/PL353318A1/xx unknown
- 2000-07-31 IL IL14787500A patent/IL147875A0/xx unknown
- 2000-07-31 WO PCT/US2000/020834 patent/WO2001008673A1/en active Application Filing
- 2000-07-31 KR KR1020027001298A patent/KR20020016928A/ko not_active Application Discontinuation
- 2000-07-31 CN CN00811177A patent/CN1367687A/zh active Pending
- 2000-07-31 HU HU0202167A patent/HUP0202167A3/hu unknown
- 2000-07-31 EP EP00952319A patent/EP1200076A4/en not_active Withdrawn
- 2000-07-31 CZ CZ2002360A patent/CZ2002360A3/cs unknown
- 2000-07-31 JP JP2001513403A patent/JP2003505502A/ja not_active Withdrawn
- 2000-07-31 MX MXPA02001204A patent/MXPA02001204A/es active IP Right Grant
- 2000-07-31 PE PE2000000756A patent/PE20010459A1/es not_active Application Discontinuation
- 2000-07-31 TR TR2002/00278T patent/TR200200278T2/xx unknown
- 2000-07-31 BR BR0012921-6A patent/BR0012921A/pt not_active Application Discontinuation
- 2000-07-31 UY UY26265A patent/UY26265A1/es not_active Application Discontinuation
- 2000-07-31 AU AU65041/00A patent/AU764716B2/en not_active Ceased
- 2000-07-31 CA CA002380081A patent/CA2380081A1/en not_active Abandoned
-
2002
- 2002-01-29 NO NO20020466A patent/NO20020466L/no not_active Application Discontinuation
- 2002-01-29 ZA ZA200201784A patent/ZA200200784B/xx unknown
- 2002-10-15 HK HK02107473.9A patent/HK1046238A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP003590A (es) | 2002-02-25 |
| TR200200278T2 (tr) | 2002-06-21 |
| CZ2002360A3 (cs) | 2002-10-16 |
| AU764716B2 (en) | 2003-08-28 |
| CO5180628A1 (es) | 2002-07-30 |
| JP2003505502A (ja) | 2003-02-12 |
| NO20020466L (no) | 2002-03-20 |
| IL147875A0 (en) | 2002-08-14 |
| PL353318A1 (en) | 2003-11-17 |
| NO20020466D0 (no) | 2002-01-29 |
| HUP0202167A3 (en) | 2006-07-28 |
| WO2001008673A1 (en) | 2001-02-08 |
| ZA200200784B (en) | 2003-01-29 |
| HUP0202167A2 (en) | 2002-10-28 |
| MXPA02001204A (es) | 2004-05-21 |
| CA2380081A1 (en) | 2001-02-08 |
| UY26265A1 (es) | 2001-03-16 |
| EP1200076A1 (en) | 2002-05-02 |
| KR20020016928A (ko) | 2002-03-06 |
| HK1046238A1 (zh) | 2003-01-03 |
| PE20010459A1 (es) | 2001-06-11 |
| EP1200076A4 (en) | 2005-02-09 |
| AU6504100A (en) | 2001-02-19 |
| CN1367687A (zh) | 2002-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60022692D1 (de) | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen | |
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE69927823D1 (de) | Hydrogel für die therapeutische behandlung von aneurysmas | |
| GB0108592D0 (en) | Therapeutic agents | |
| NO20005884L (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
| BR0012921A (pt) | Compostos calcilìticos | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| DE69805305T2 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ES2175356T3 (es) | Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares. | |
| DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| ATE230741T1 (de) | 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen | |
| ATE330604T1 (de) | Behandlung von manischen erkrankungen | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| ATE251167T1 (de) | Oxazinocarbazole zur behandlung von cns- erkrankungen | |
| DE69806062T2 (de) | Kombinationstherapie zur behandlung von aids | |
| ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis | |
| TR200003084T2 (tr) | Paroxetine askorbat | |
| DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten | |
| ATE204167T1 (de) | Antikonvulsive derivate zur behandlung von psoriasis | |
| ATE236159T1 (de) | Neuartige bispidin-derivate, die sich zur behandlung von herzrhythmusstörungen eignen | |
| DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |